177 results
8-K
EX-99.1
VTAK
Catheter Precision Inc.
2 Apr 24
Results of Operations and Financial Condition
4:20pm
-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements … affected, litigation and other legal proceedings may adversely affect our business, if we make acquisitions or divestitures, we could encounter
8-K
EX-99.1
VTAK
Catheter Precision Inc.
11 Jan 24
CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 Results
4:15pm
of the Private Securities Litigation Reform Act of 1995 that are subject to substantial risk and uncertainties. Forward-looking statements can … this product, if we experience significant disruptions in our information technology systems, our business may be adversely affected, litigation and other
POS AM
VTAK
Catheter Precision Inc.
22 Dec 23
Prospectus update (post-effective amendment)
5:16pm
of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Exchange Act and the Private Securities Litigation Reform … VIVO, Amigo and LockeT; litigation outcomes; the listing status of our common stock; and existing and/or prospective customers.
Our forward-looking
POS AM
VTAK
Catheter Precision Inc.
22 Dec 23
Prospectus update (post-effective amendment)
5:15pm
, as amended (the “Securities Act”), Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995, and such statements are subject … , as well as financial performance, expectations with respect to our business and product development, including VIVO, Amigo and LockeT; litigation outcomes
8-K
EX-99.1
9bvf zyg621w44
22 Dec 23
CATHETER PRECISION, INC. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
4:15pm
8-K
EX-99.1
apk3ises9vrogqf
18 Dec 23
CATHETER PRECISION, INC. Reports Second Quarter Results of Operations
4:31pm
8-K
EX-99.1
n3opu3t8ixd j4g6h
25 Aug 23
Catheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
4:15pm
8-K
yc74ut1mb03x
4 Aug 23
Amendments to Articles of Incorporation or Bylaws
4:19pm
8-K
EX-99.1
27s0clci4qt0ig fd
2 Jun 23
Ra Medical Systems Announces First Quarter Results
5:46pm
8-K
EX-99.1
tyoo348y5pz
30 May 23
Ra Medical Systems Receives Notice from NYSE American
4:25pm
8-K
EX-99.1
8hw r25od6u15v3tmflu
22 May 23
Ra Medical Systems Announces Delayed 10-Q Filing
4:15pm
8-K
EX-99.1
0umqp
16 May 23
Ra Medical Systems Provides First Corporate Update Since Merger
4:16pm
8-K
EX-99.1
mtw0qn
18 Apr 23
Ra Medical Announces Resignation of CEO
6:04pm
8-K
EX-99.1
fbsbrkhocy qxyi
30 Mar 23
Ra Medical Systems Announces Change in Chief Financial Officer Position Previous Acting CFO Position Replaced with Permanent Appointment
4:38pm
8-K/A
EX-99.3
565 w5t3lfz109pv19jx
29 Mar 23
Other Events
4:39pm